The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

A federal appeals court on Wednesday revived part of a lawsuit accusing the Federal Reserve Bank of New York of illegally ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

TUESDAY, July 1, 2025 (HealthDay News) — On Monday, the U.S. Supreme Court said it will not hear a case brought by a group ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...